Charles River Laboratories International Aktie
157,95
EUR
-2,25
EUR
-1,40
%
181,44
USD
-3,51
USD
-1,90
%
Charles River Laboratories International jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Charles River Laboratories International Aktie Analyse
| 14.12.18 | Charles River Laboratories International Buy | Deutsche Bank AG | |
| 26.04.16 | Charles River Laboratories International Buy | Gabelli & Co | |
| 13.05.10 | Charles River Laboratories International kaufen | Robert W. Baird & Co. Incorporated | |
| 02.05.07 | Charles River Laboratories International outperform | Robert W. Baird | |
| 17.04.07 | Charles River Laboratories International overweight | Lehman Brothers | |
| 15.02.07 | Charles River Laboratories International buy | Jefferies & Co | |
| 04.05.06 | Charles River Laboratories International overweight | Lehman Brothers | |
| 04.05.06 | Charles River Laboratories International Overweight | Lehman Brothers | |
|
Werbung
|
|||
| 13.12.05 | Charles River Laboratories International | Biotech-Report | |
| 27.10.05 | Charles River Laboratories International outperform | Goldman Sachs | |
| 27.10.05 | Charles River Laboratories International Outperform | Goldman Sachs | |
Werbung
Werbung